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ABSTRACT 
Metabolic syndrome (MetS) is associated with obesity, dyslipemia, type 2 diabetes 
and chronic low-grade inflammation. The aim of this study was to determine the role 
of high-fat low-cholesterol diets (HFLCDs) rich in SFAs (HFLCD-SFAs), MUFAs 
(HFLCD-MUFAs) or MUFAs plus omega-3 long-chain PUFAs (HFLCD-PUFAs) on 
polarisation and inflammatory potential in bone marrow-derived macrophages 
(BMDMs) from niacin (NA)-treated Lep
ob/ob
LDLR
−/−
 mice. Animals fed with 
HFLCD-SFAs had increased weight and serum triglycerides, and their BMDMs 
accumulated triglycerides over the animals fed with HFLCD-MUFAs or -PUFAs. 
Furthermore, BMDMs from animals fed with HFLCD-SFAs were polarised towards 
M1 phenotype with functional competence to produce pro-inflammatory cytokines, 
whereas BMDMs from animals fed with HFLCD-MUFAs or -PUFAs were skewed to 
anti-inflammatory M2 phenotype. These findings open opportunities for developing 
novel nutritional strategies with olive oil as the most important dietary source of 
MUFAs (notably oleic acid) to prevent development and progression of metabolic 
complications in the NA-treated MetS. 
 
Keywords: Olive oil, niacin, bone marrow-derived macrophages, metabolic 
syndrome, inflammation
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INTRODUCTION 
Niacin (NA, also commonly known as nicotinic acid or vitamin B3) is a water-soluble 
vitamin that is converted in vivo to nicotinamide adenine dinucleotide (NAD
+
), a 
coenzyme involved in the lipid catabolism.
1
 NA has been established as a broad-
spectrum lipid-modulating drug.
2
 However, it is becoming increasingly evident that 
NA possesses pleiotropic effects upon attenuating obesity-induced inflammation.
3,4
 
During weight gain, white adipose tissue (WAT) resident macrophages may undergo 
a ‘phenotypic switch’ from an anti-inflammatory M2 to a pro-inflammatory M1 
phenotype, linking to the emergence of insulin resistance and metabolic syndrome 
(MetS)-related disorders.
5
 Nutritional-based strategy to counteract these 
complications is to decrease the consumption of energy-dense high-fat diets.
6
 
However, it is unknown whether the type of dietary fats plays any role on macrophage 
plasticity during obesity-related inflammation in association with NA treatment in 
MetS. 
 
MATERIALS AND METHODS 
Fatty acid composition of dietary fats 
The fatty acid (FA) composition of dietary fats [cow's milk cream, rich in saturated 
FAs (SFAs); refined olive oil, rich in monounsaturated FAs (MUFAs); and refined 
olive oil plus eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), rich in 
MUFAs and omega-3 long-chain polyunsaturated FAs (PUFAs)] was determined by 
the method described in EEC/796/2002,
7
 using a gas chromatography system (HP-
5890, Hewlett-Packard) equipped with flame ionization detector and a SP-2380 
capillary column (Supelco, 30 m x 0.32 mm) packed with cyan propyl siloxane (0.25 
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µm). The initial column temperature was 165 ºC, which was held for 10 min, then 
programmed from 165 ºC to 200 ºC at 1.5 ºC/min. Injector and detector temperature 
were 250 ºC, with the carrier gas H2. The FA composition of different dietary fats is 
detailed in Table 1. 
Animal diets and experimental design 
Male Lep
ob/ob
LDLR
−/−
 mice bread onto a C57BL/6J background (B6.Cg-Lepob 
Ldlrtm1Her/J, The Jackson Laboratory, Bar Harbor, ME) was used for the study. 
These mice are obese and develop plasma lipid alterations that closely reflect MetS-
related hyperlipidemia.
8
 All diets were prepared by Panlab Laboratoires (SAFE, 
Augy, France) and presented as pellets to the animals. Mice received one of the 
following diets for 8 weeks: a standard normal-fat diet (low-fat low-cholesterol diet, 
LFLCD) containing 3% energy as fat, used as control, or high-fat low-cholesterol 
diets (HFLCDs), which contained 24% energy as fat. All the diets were based on the 
standard rodent diet A04-10, containing 0.01% cholesterol, 20 mg/kg BHT, and 3% 
binder. Three different HFLCDs were prepared by replacing the fat source from A04-
10 diet by cow's milk cream (21% energy) (HFLCD-SFAs), refined olive oil (21% 
energy) (HFLCD-MUFAs) or refined olive oil (20% energy) plus EPA+DHA (1% 
energy) (HFLCD-PUFAs). All the diets contained equal proportion of protein (19.5% 
energy) and carbohydrate was used to adjust the total energy content. 
After weaning, mice were randomly allocated into 4 groups (n = 10 per group) as 
follows: (1) group that received LFLCD; (2) group that received HFLCD-SFAs; (3) 
group that received HFLCD-MUFAs; and (4) group that received HFLCD-PUFAs. 
The four groups received NA (1%, w/v) in the drinking water. Body weight, food, and 
water intake were daily evaluated. Sacrifice of all animals was carried out within the 
animal facilities (Instituto de Biomedicina de Sevilla, IBiS), at the beginning of the 
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light cycle and after 10 h of food deprivation. Animals were euthanized with an 
overdose of pentobarbital (1:10 in PBS, 150 mg/kg body weight). Serum samples 
were obtained from blood by centrifugation at 4000 rpm for 15 min at 4 ºC. Total 
cholesterol (TC) and triglycerides (TGs) were assessed by colorimetric assay kit (Bio-
Science-Medical, Madrid, Spain). All animal protocols received appropriate 
institutional approval (Animal care and Use Committee of the University of Seville) 
and were performed according to the official rules formulated in the Spanish law on 
the care and use of experimental animals (UE Directive of 2010: 2010/63/UE; RD 
53/2013). 
Isolation of bone marrow cells and differentiation into BMDMs 
Cells from bone marrow were isolated and pooled for each group of mice. Femora 
and tibiae were aseptically removed and dissected free of adherent soft tissue. The 
bone ends were cut, and the marrow cavity was flushed out into a petri dish by slowly 
injecting ice-cold PBS solution at one end of the bone using a sterile 21-gauge needle. 
The bone marrow suspension was carefully agitated with a plastic Pasteur pipette to 
obtain a single cell suspension. Cells were washed and depleted of red blood cells 
using a hypotonic lysis buffer.
9
 After washing twice with PBS, the cells were cultured 
and differentiated into BMDMs for 6 days at 37 ºC under a humidified atmosphere 
containing 5% CO2 in 12-well dishes containing RPMI 1640 medium (containing 50 
units/mL penicillin G, 50 µg/mL streptomycin, 2 mM glutamine) plus 10% heat-
inactivated FBS and 20 ng/mL of murine M-CSF. As controls for M1 and M2 
polarisation, BMDMs from animals fed with LFLCD were further exposed to LPS 
(100 ng/mL) plus IFNγ (20 ng/mL) and to IL-4 (20 ng/mL), respectively, for 
additional 24 h.
10 
Measurement of the lipid content in lipid-laden BMDMs 
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BMDMs were washed twice with PBS and scraped in 400 µL of 0.9% NaCl. After 
sonication, the protein content of the lysate was measured using the Bradford protein 
assay (BioRad Laboratories, Madrid, Spain). Cellular lipids were extracted using 
hexane/isopropanol (3:2, v/v). The content of TC and TGs was measured using the 
aforementioned assay kits.
9 
RNA isolation and RT-qPCR analysis 
Total RNA extraction from BMDMs was carried out using Trisure Reagent (Bioline, 
London, UK). RNA quality was assessed by A260/A280 ratio in a NanoDrop ND-1000 
Spectrophotometer (Thermo Scientific, Wilmington, DE, USA). RNA (1 µg) was 
subjected to reverse transcription (iScript, BioRad). An amount of 20 ng of the 
resulting cDNA was used as a template for real-time PCR amplifications. The mRNA 
levels for specific genes were determined in a CFX96 system (BioRad). For each 
PCR reaction, cDNA template was added to Brilliant SYBR green QPCR Supermix 
(BioRad) containing the primer pairs for the corresponding gene. Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was used as housekeeping gene. The sequence 
and information for the primers are shown in Supplemental Table 1. All 
amplification reactions were performed in triplicate and average threshold cycle (Ct) 
numbers of the triplicates were used to calculate the relative mRNA expression of 
candidate genes. The magnitude of change of mRNA expression for candidate genes 
was calculated by using the standard 2
-(∆∆Ct)
 method. All data were normalized to the 
content of housekeeping gene and expressed as percentage of control. 
Statistical analysis 
All values in the figures and text are expressed as arithmetic means ± SD. For ex vivo 
studies, serum and BMDMs isolated from the animals were pooled into four distinct 
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fractions. Experiments were carried out in triplicate. Data were evaluated with Graph 
Pad Prism Version 5.01 software. The statistical significance of any difference in each 
parameter among the groups was evaluated by one-way analysis of variance 
(ANOVA); using Tukey multiple comparisons test as post hoc test. P values of <0.05 
were considered statistically significant. 
RESULTS AND DISCUSSION 
We have analysed the effects on macrophage plasticity of a LFLCD and HFLCDs of 
different FA compositions (SFAs, MUFAs, and MUFAs + omega-3 PUFAs) in NA-
treated Lep
ob/ob
LDLR
−/−
mice at the end of an 8-week diet period. Mean daily food 
intake (LFLCD, 4.07 ± 0.32; HFLCD-SFAs, 4.15 ± 0.61; HFLCD-MUFAs, 4.01 ± 
0.47; HFLCD-PUFAs, 4.17 ± 0.41 g/mouse) and water intake (LFLCD, 6.28 ± 0.83; 
HFLCD-SFAs, 6.35 ± 1.01; HFLCD-MUFAs, 6.12 ± 0.77; HFLCD-PUFAs, 6.11 ± 
0.81 mL/mouse) were not different among the four diet groups. However, significant 
differences were observed from the second week for body weight and final body 
weight gain in animals subjected to the different diets (HFLCD-SFAs > HFLCD-
MUFAs = HFLCD-PUFAs > LFLCD) (Figs. 1A and 1B). These results support the 
notion of poor utilization of dietary SFAs for energy and their preferential storage in 
WAT.
11
 In agreement with previous studies,
8
 HFLCDs induced circulating lipid 
abnormalities in Lep
ob/ob
LDLR
−/−
mice (Figs. 1C and 1D); additionally, we observed 
that serum TC levels were not different between HFLCD groups but higher than the 
LFLCD group (Fig. 1C), whereas serum TG levels were as follows: HFLCD-SFAs > 
HFLCD-MUFAs = HFLCD-PUFAs > LFLCD (Fig. 1D). Similar patterns were 
observed for intracellular TC (Fig. 2A) and TGs (Fig. 2B) in BMDMs obtained from 
the different diet groups. TG storage has been previously shown to increase in murine 
macrophages upon activation in vitro,
12
 an effect that is blunted in the presence of 
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NA.
13
 Our study further expands this knowledge and is suggestive of an in vivo 
predisposition of macrophages for lipid accumulation in a dietary FA-dependent 
manner in a setting of NA treatment. 
Lipid accumulation in macrophages contributes to foam cell formation, which is 
associated with chronic subclinical inflammation and constitutes a hallmark of early 
atherosclerosis.
14
 It was noteworthy that BMDMs from animals fed with HFLCD-
SFAs had higher mRNA levels of pro-inflammatory M1 phenotypic markers CCR7 
and iNOs
5
 than BMDMs from animals fed with HFLCD-MUFAs or HFLCD-PUFAs, 
with no differences between both diets (Figs. 3A and 3B). However, gene expression 
of anti-inflammatory M2 phenotypic markers MRC1 and Arg-1 (Cita) was 
upregulated in BMDMs from animals fed with HFLCD-MUFAs and HFLCD-PUFAs 
but not with HFLCD-SFAs (Figs. 3C and 3D). There was also a decrease in the 
transcriptional activity of pro-inflammatory cytokine genes TNF-α, IL-1β, IL-6 and 
MCP-1 in BMDMs from animals fed with HFLCD-MUFAs and HFLCD-PUFAs 
when compared to BMDMs from animals fed with HFLCD-SFAs (Figs. 3E-3H). 
These findings are in accordance with previous studies on the potential of SFAs to 
promote inflammatory signals
15
 in contrast to unsaturated Fas
6,16
 and demonstrate 
divergent effects for SFAs with regard to MUFAs or MUFAs plus omega-3 long-
chain PUFAs associated with NA in driving macrophage plasticity. BMDMs from 
animals fed with HFLCD-SFAs resembled M1 macrophages, whereas BMDMs from 
animals fed with HFLCD-MUFAs or HFLCD-PUFAs resulted in a macrophage 
phenotype close to that of M2. It is tempting to speculate that the nature of dietary fats 
could be behind the unexpected failure of some human trials to demonstrate the 
beneficial effects of NA in reducing cardiovascular disease (CVD) events.
17-19
 Future 
studies are needed to determine the role of the diet in high-risk CVD patients 
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refractory to NA therapy. Taken together, our observations suggest that the 
combination of NA and dietary sources of MUFAs (e.g. olive oil) and of EPA and 
DHA may be useful for the management of chronic activation of the innate immune 
system in MetS. 
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ABBREVIATIONS 
BMDM: Bone marrow-derived macrophage 
DHA: Docosahexaenoic acid 
EPA: Eicosapentaenoic acid 
FA: Fatty acid 
HFLCD: High-fat low-cholesterol diet 
IFN: Interferon 
IL: Interleukin 
LDLR: Low density lipoprotein receptor 
LFLCD: Low-fat low-cholesterol diet 
LPS: Lipopolysaccharide 
M-CSF: Macrophage colony stimulating factor 
MetS: Metabolic syndrome 
MUFA: Monounsaturated fatty acid 
NA: Niacin 
NAD: Nicotinamide adenine dinucleotide 
PBS: Phosphate buffered saline 
PUFA: Polyunsaturated fatty acid 
SFA: Saturated fatty acid 
TC: Total Cholesterol 
TG: Triglyceride 
WAT: White adipose tissue 
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Figure Legends 
Figure 1. Body weight evolution (A), body weight gain (B), serum total cholesterol 
(C) and triglycerides (D) in male Lep
ob/ob
LDLR
−/−
 mice subjected to low-fat (LFLCD) 
and high-fat (HFLCD-SFAs, HFLCD-MUFAs and HFLCD-PUFAs) diets and NA 
(1%, w/v) in the drinking water for 8 weeks. Values are presented as means ± SD (n = 
10). Different letters denote statistical differences (P <0.05). 
Figure 2. Accumulation of total cholesterol (A) and triglycerides (B) in BMDMs 
from male Lep
ob/ob
LDLR
−/−
 mice subjected to low-fat (LFLCD) and high-fat 
(HFLCD-SFAs, HFLCD-MUFAs and HFLCD-PUFAs) diets and NA (1%, w/v) in 
the drinking water for 8 weeks. Values are presented as means ± SD (n = 10). 
Different letters denote statistical differences (P <0.05). 
Figure 3. Relative mRNA levels of CCR7 (A), iNOs (B), MRC1 (C), Arg-1 (D), 
TNF-α (E), IL-1β (F), IL-6 (G) and MCP-1 (H) in BMDMs from male 
Lep
ob/ob
LDLR
−/−
 mice subjected to low-fat (LFLCD) and high-fat [HFLCD-SFAs 
(black bars), HFLCD-MUFAs (dark grey bars) and HFLCD-PUFAs (light grey bars)] 
diets and NA (1%, w/v) in the drinking water for 8 weeks. M1 and M2 control 
macrophages (white bars) were generated as indicated in the Materials and methods 
section. Values are presented as means ± SD (n = 10). Different letters denote 
statistical differences (P <0.05). 
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Table 1. Fatty acid composition of dietary fats. 
 Cow’s milk 
cream 
Refined olive oil Refined olive oil 
plus EPA+DHA 
Fatty acid g/100 g of fatty acid  
10:0, capric 2.47 ± 0.13 - - 
12:0, lauric 3.09 ± 0.42 - - 
14:0, myristic 10.87 ± 0.91 - - 
16:0, palmitic 35.54 ± 0.82 20.41 ± 0.89 20.52 ± 0.64 
16:1(n-7), palmitoleic 3.60 ± 0.32 0.97 ± 0.17 0.82 ± 0.12 
18:0, stearic 11.49 ± 0.75 5.70 ± 0.11 4.49 ± 0.36 
18:1(n-9), oleic 25.33 ± 0.71 61.86 ± 1.23 61.54 ± 0.97 
18:2(n-6), linoleic 4.27 ± 0.82 7.97 ± 0.65 8.04 ± 0.53 
18:3(n-3), α-linolenic 0.39 ± 0.05 1.04 ± 0.13 0.94 ± 0.03 
20:5(n-3), eicosapentaenoic - - 0.92 ± 0.09 
22:6(n-3), docosahexaenoic - - 0.72 ± 0.10 
Others 2.95 ± 1.72 2.05 ± 1.08 2.01 ± 0.88 
Total SFAs 63.46 ± 1.86a 26.11 ± 1.03b 25.01 ± 0.85b 
Total MUFAs 28.93 ± 0.83b 62.83 ± 1.35a 62.36 ± 1.03a 
Total PUFAs 4.66 ± 0.79c 9.01 ± 0.73b 10.62 ± 0.68a 
Values are means ± SD, n = 3. Different superscript letters denote mean values in a 
row significantly different (P <0.05). 
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Supplementa Table 1. Sequences of RT-qPCR primers for gene expression analysis. 
Target No. GenBank           Direction Sequence (5’ --> 3’) 
GAPDH NM_001289726 Forward 
Reverse 
AACTTTGGCATTGTGGAAGG 
ACACATTGGGGGTAGGAACA 
CCR7 NM_001301713 Forward 
Reverse 
CCAGGCACGCAACTTTGAG 
ACTACCACCACGGCAATGATG 
iNOs NM_010927 Forward 
Reverse 
CACCTTGGAGTTCACCCAGT 
ACCACTCGTACTTGGGATGC 
MRC1 NM_008625.2 Forward 
Reverse 
ATGCCAAGTGGGAAAATCTG 
TGTAGCAGTGGCCTGCATAG 
Arg-1 NM_007482 Forward 
Reverse 
GTGAAGAACCCACGGTCTGT 
CTGGTTGTCAGGGGAGTGTT 
TNF-α  NM_001278601 Forward 
Reverse 
AGCCCCCAGTCTGTATCCTT 
CTCCCTTTGCAGAACTCAGG 
IL-1β NM_008361 Forward 
Reverse 
GCCCATCCTCTGTGACTCAT 
AGGCCACAGGTATTTTGTCG 
IL-6 NM_031168 Forward 
Reverse 
AGTTGCCTTCTTGGGACTGA 
TCCACGATTTCCCAGAGAAC 
MCP-1 NM_011331 Forward 
Reverse 
AGGTCCCTGTCATGCTTCTG 
TCTGGACCCATTCCTTCTTG 
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Niacin and olive oil promote the skewing to M2 phenotype in bone 
marrow-derived macrophages of mice with metabolic syndrome	
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